AC
TEVA icon

Apex Capital’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Apex Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$66.1M Buy
1,006,800
+31,800
+3% +$1.97M 7.05% 1
2015
Q3 		$55M Buy
975,000
+250,000
+34% +$16.2M 5.23% 2
2015
Q2 		$42.8M Buy
725,000
+325,000
+81% +$20M 3.71% 6
2015
Q1 		$24.9M Buy
+400,000
New +$23.3M 1.79% 21

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Waddell & Reed Financial
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Apex Capital's TEVA Position: Q4 2015 in Review

Apex Capital increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 3.3% in Q4 2015, buying an estimated $1.97M and bringing the position to 1,006,800 shares worth $66.1M. The position accounts for 7.05% of the portfolio, ranked #1.

Apex Capital first reported a position in TEVA in Q1 2015 and has held it in 4 quarters since. 877 funds tracked by Wall St. Rank hold TEVA as of Q4 2015.

  • Apex Capital held 1,006,800 shares of Teva Pharmaceutical Industries Limited worth $66.1M as of Q4 2015.
  • Apex Capital bought 31,800 Teva Pharmaceutical Industries Limited shares in Q4 2015, an estimated $1.97M.
  • Teva Pharmaceutical Industries Limited made up 7.05% of Apex Capital's portfolio in Q4 2015, its #1 holding.
  • Apex Capital first reported a position in Teva Pharmaceutical Industries Limited in Q1 2015 and has held it in 4 quarters since.
  • 877 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2015.

Based on Apex Capital's 13F filing for Q4 2015, filed 16 Feb 2016.